BiomimX
PrivateLast Round
Grant
Dec 6, 2023
Total Funding Raised
$1.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BiomimX Srl is a biotechnology company that is a pioneer in Organ-on-a-Chip (OoC) technology, producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiomimX Comparables
Compare BiomimX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlveoliX AG | 90% | |
| React4Life | 90% | |
| DLOC Biosystems | 89% |
BiomimX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 6, 2023 | ||||
| Accelerator | Oct 20, 2022 | ||||
| Grant | Mar 3, 2022 | ||||
| Grant | Mar 1, 2022 | ||||
| Grant | May 20, 2021 | ||||
Grant | May 1, 2021 |
BiomimX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Berkeley SkyDeck Europe, Milano | Accelerator |
| Berkeley SkyDeck | Accelerator |
| Camera di Commercio di Milano Monza Brianza Lodi | Grant |
| EIT Health | Grant |
| Swiss National Science Foundation | Grant |
| Invitalia | Grant |
| Berkeley SkyDeck Europe, Milan | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 598% MoM.
- May 20, 2026
Monthly visitors grew 97% MoM.
BiomimX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BiomimX's valuation, stock price, and market status.
Is BiomimX a public or private company?
BiomimX is a private company.
What is the current stock price of BiomimX?
BiomimX is a private company with no public stock price. No recent secondary market data is available.
How much is BiomimX worth (valuation)?
Valuation information for BiomimX is not publicly available.
Can I buy BiomimX stock?
BiomimX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BiomimX's last funding round?
BiomimX's most recent funding round was Grant on December 6, 2023.
Who are the main investors in BiomimX?
Key investors in BiomimX include Berkeley SkyDeck Europe, Milano, Camera di Commercio di Milano Monza Brianza Lodi, EIT Health, Swiss National Science Foundation, Invitalia.
Will BiomimX IPO soon?
No public IPO plans have been announced for BiomimX.
How can I track BiomimX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BiomimX's secondary market activity and sign up for updates.